The first revision of the ERA guideline on environmental risk assessment
by Giuliana Miglierini It took eight years before revision 1 of the EMA guideline on environmental risk assessment…
Consultation on the revision of the Guideline on the chemistry of active substances
by Giuliana Miglierini The public consultation on the draft Guideline on the chemistry of active substances is open…
Accelerating Clinical Trials in the European Union (ACT-EU)
The Multistakeholder Platform (MSP) and the position of the European Industrial Pharmacists Group (EIPG) by Rebecca Rebecca Stanbrook…
EIPG Meeting in Rome in April
By Piero Iamartino The 2024 General Assembly of EIPG (European Industrial Pharmacists Group) was held in Rome on…
Environmental sustainability: the EIPG perspective
Piero Iamartino Although the impact of medicines on the environment has been highlighted since the 70s of the…
EMA’s pilot scheme for academic and non-profit development of ATMPs
by Giuliana Miglierini Advanced therapy medicinal products (ATMPs) are often developed by academic and non-profit organisations, because of…